Adaptation and initial results of the Polish version of the GA2LEN Chronic Urticaria Quality Of Life Questionnaire (CU-Q2oL)

Journal of Dermatological Science

Volumn 62, Issue 1, 2011, Pages 36-41

  Brzoza, Z ^a   Badura Brzoza, K ^a   Mlynek A ^b,c   Magerl, M ^c   Baiardini, I ^d   Canonica, G W ^d   Weller, K ^c   Kocaturk E ^e   Kalogeromitros, D ^c,f   Zalewska Janowska, A ^b   Zuberbier, T ^c   Maurer, M ^c  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF GENOA   (Italy)

^e GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^f NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Chronic urticaria; Quality of life; Questionnaire

Indexed keywords

ADULT; ARTICLE; CHRONIC URTICARIA; CONTROLLED STUDY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; EATING; FEMALE; GA2LEN CHRONIC URTICARIA QUALITY OF LIFE QUESTIONNAIRE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; POLAND; PREDICTION; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM; SKINDEX 29 QUESTIONNAIRE; SLEEP; SWELLING; VALIDITY;

ADULT; CHRONIC DISEASE; DERMATOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; POLAND; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; URTICARIA;

EID: 79952706741     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.01.010     Document Type: Article

References (29)

1. Zuberbier T., Balke M., Worm M., Edenharter G., Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol 2010, 35:869-873.
2. Staubach P., Eckhardt-Henn A., Dechene M., Vonend A., Metz M., Magerl M., et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006, 154:294-298.
3. Brzoza Z., Kasperska-Zajac A., Badura-Brzoza K., Matysiakiewicz J., Hese R.T., Rogala B. Decline in dehydroepiandrosterone sulfate observed in chronic urticaria is associated with psychological distress. Psychosom Med 2008, 70:723-728.
4. Yang H.Y., Sun C.C., Wu Y.C., Wang J.D. Stress, insomnia, and chronic idiopathic urticaria - a case-control study. J Formos Med Assoc 2005, 104:254-263.
5. Baiardini I., Giardini A., Pasquali M., Dignetti P., Guerra L., Specchia C., et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 2003, 58:621-623.
6. O'Donell B.F., Lawlor F., Simpson J., Morgan M., Greaves M.W. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997, 136:197-201.
7. Poon E., Seed P.T., Greaves M.W., Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999, 140:667-671.
8. Młynek A., Zalewska-Janowska A., Martus P., Staubach P., Zuberbier T., Maurer M. How to assess disease activity in patients with chronic urticaria?. Allergy 2008, 63:777-780.
9. Zuberbier T., Asero R., Bindslev-Jensen C., Canonica G.W., Church M.K., Giménez-Arnau A., et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009, 64:1417-1426.
10. 2LEN taskforce position paper. Allergy 2010, 65:290-295.
11. Ozkan M., Oflaz S.B., Kocaman N., Ozseker F., Gelincik A., Büyüköztürk S., et al. Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2007, 99:29-33.
12. 2oL). Allergy 2005, 60:1073-1078.
13. 2oL). J Investig Allergol Clin Immunol 2008, 18:426-432.
14. Młynek A., Magerl M., Hanna M., Lhachimi S., Baiardini I., Canonica G.W., et al. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009, 64:927-936.
15. Finlay A.Y. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997, 136:305-314.
16. Floyd F.J., Widaman K.F. Factorial analysis in the development and refinement of clinical assessment instruments. Psychol Assess 1995, 7:286-299.
17. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006, 4:79-98. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health.
18. Wild D., Grove A., Martin M., Eremenco S., McElroy S., Verjee-Lorenz A., et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005, 8:94-104.
19. Guillemin F., Bombardier C., Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed measures. J Clin Epidemiol 1993, 46:1417-1432.
20. Herdman M., Fox-Rushby J., Badia X. A model of equivalence in the cultural adaptation of HRQOL instruments: the universalist approach. Qual Life Res 1998, 7:323-335.
21. Szepietowski J., Salomon J., Finlay A.Y., Klepacki A., Chodynicka B., Marionneau N., et al. Wskaźnik wpływu dolegliwości skórnych na jakość ycia - Dermatology Life Quality Index (DLQI): polska wersja jzykowa. Dermatol Klin 2004, 6:63-70.
22. Steuden S., Janowski K. Zastosowanie kwestionariusza Skindex do pomiaru jakości ycia u pacjentów z łuszczyc. Przegl Dermatol 2001, 88:41-48.
23. Lennox R.D., Leahy M.J. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol 2004, 93:142-146.
24. Shikiar R., Harding G., Leahy M., Lennox R. Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria. Health Qual Life Outcomes 2005, 3:36-40.
25. Gorsuch R.L. Factor analysis 1983, Lawrence Erlbaum, Hillsdale, NJ.
26. Rosner B. Foundamentals of biostatistics 1995, Duxbury Press, Belmont, CA, p. 519.
27. Zuberbier T., Asero R., Bindslev-Jensen C., Canonica G.W., Church M.K., Giménez-Arnau A.M., et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009, 64:1427-1443.
28. Maurer M., Ortonne J.P., Zuberbier T. Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy 2009, 64:581-588.
29. Maurer M., Ortonne J.P., Zuberbier T. Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients. Br J Dermatol 2009, 160:633-641.